Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug–drug interactions

L Elens, LJ Langman, DA Hesselink… - Therapeutic drug …, 2020 - journals.lww.com
Background: COVID-19 is a novel infectious disease caused by the severe acute respiratory
distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently …
被引用次数：73 相关文章
[PDF] universiteitleiden.nl

[PDF][PDF] Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug …

L Elens, LJ Langman… - Ther Drug …, 2020 - scholarlypublications …
Background: COVID-19 is a novel infectious disease caused by the severe acute respiratory
distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently …

Pharmacologic treatment of transplant recipients infected with SARS-CoV-2 considerations regarding therapeutic drug monitoring and drug-drug interactions

L Elens, LJ Langman, DA Hesselink… - Therapeutic Drug …, 2020 - univ-rennes.hal.science
Background-COVID-19 is a novel infectious disease caused by the severe acute respiratory
distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently …

Pharmacologic treatment of transplant recipients infected with SARS-CoV-2 considerations regarding therapeutic drug monitoring and drug-drug interactions.

L Elens, LJ Langman, DA Hesselink, S Bergan… - 2020 - cabidigitallibrary.org
Background: COVID-19 is a novel infectious disease caused by the severe acute respiratory
distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently …
[PDF] uclouvain.be

[PDF][PDF] Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug …

L Elens, LJ Langman, DA Hesselink, S Bergan… - 2020 - dial.uclouvain.be
Background: COVID-19 is a novel infectious disease caused by the severe acute respiratory
distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently …

Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions

L Elens, LJ Langman, DA Hesselink… - Therapeutic drug …, 2020 - pubmed.ncbi.nlm.nih.gov
Background COVID-19 is a novel infectious disease caused by the severe acute respiratory
distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently …

Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.

L Elens, LJ Langman, DA Hesselink… - Therapeutic Drug …, 2020 - europepmc.org
Background COVID-19 is a novel infectious disease caused by the severe acute respiratory
distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently …

Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions

L Elens, LJ Langman, DA Hesselink… - Therapeutic Drug …, 2020 - journals.lww.com
Background: COVID-19 is a novel infectious disease caused by the severe acute respiratory
distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently …

Pharmacologic treatment of transplant recipients infected with SARS-CoV-2 considerations regarding therapeutic drug monitoring and drug-drug interactions

L Elens, LJ Langman, DA Hesselink… - Therapeutic Drug …, 2020 - hal.science
Background-COVID-19 is a novel infectious disease caused by the severe acute respiratory
distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently …

Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions

L Elens, LJ Langman, DA Hesselink, S Bergan… - Therapeutic Drug …, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> COVID-19 is a novel infectious
disease caused by the severe acute respiratory distress (SARS)-coronavirus-2 (SARS-CoV …